Presenters at the GPCME in Rotorua

We are very pleased Lung Health is on the programme at the 2017 GPCME in Rotorua. Our thanks to Dr Richard Sullivan (Chair), Dr Chris Lewis, Dr John Ashton (Lung Cancer Patient Ambassador) and Dr Greg Frazer (Special Advisory Committee) for delivering a very thorough and professional lung health plenary at the 2017 GPCME in […]

Kiwis diagnosed with asbestos and other dust-related diseases whose exposure occurred while working in Australia may be entitled to compensation.

There are different statutory and common law entitlements in every state of Australia. Depending on where you were exposed, you may have entitlements to common law damages, pensions and/or statutory benefits. You may be legally entitled to claim compensation if you are suffering from: • asbestosis • lung cancer • asbestos related pleural disease • […]

Dr Richard Sullivan to Chair Lung Health Plenary at the 2017 GPCME

We are thrilled to advise that one of New Zealand’s leading Medical Oncologists, Dr Richard Sullivan MBChB, FRACP will chair the lung health plenary at the 2017 GPCME (General Practice Conference and Medical Exhibition) in Rotorua. Dr Sullivan is also one of the quality presenters and his presentation will engage participants with Maximising Patient Outcomes. […]

Vast vaping

It’s no surprise to see the huge growth reported in global sales of e cigarettes. Whilst e cigarettes at this stage are considered much safer than tobacco products and are being promoted widely, we do have concerns because the use of e cigarettes amongst adolescents is increasing rapidly. This poses the risk that our younger […]

Minimise the risk of pneumococcal pneumonia this winter

June 1st is acknowledged as the official start of winter. Pneumococcal pneumonia (lung infection) is more common and more serious in older adults. The enclosed infographic highlights important facts about pneumococcal pneumonia. Talk to your doctor about ways to minimise the risk this winter. Become a lung health champion by sharing this poster.

List of private providers for lung cancer patients

We continue to receive enquiries from lung cancer patients with the PD-L1 expression about access to KEYTRUDA (Pembrolizumab). Because KEYTRUDA is not funded in New Zealand for all registered indications, patients may need to see a private provider to have this immunotherapy treatment prescribed. Some doctors working in public hospitals may be able to help […]

Suicide Risk Quadruples After Lung Cancer Diagnosis

By Foreign Affairs Publisher / May 25, 2017 / Comments Off on Suicide Risk Quadruples After Lung Cancer Diagnosis People with lung cancer have a strikingly higher-than-normal risk of suicide, a new study finds. While a cancer diagnosis on its own significantly raises the risk of suicide, the study found that a lung cancer diagnosis […]